Rybelsus (semaglutide)

pCPA File Number: 21518

Negotiation Status:

Concluded without agreement

Indication(s):

Diabetes Mellitus, Type 2

Sponsor/Manufacturer:

Novo Nordisk Canada Inc.

CDA-AMC Project Number:

SR0637-000

pCPA Engagement Letter Issued:

2021-11-04

Negotiation Process Concluded:

2022-12-20